Crosstalks

#06 Workshop on Access & Transparency (Science and industry lunch 6)

Info

Date: 
24 Sep 2008
Place: 

Promotiezaal, Vrije Universiteit Brussel | Building D, Pleinlaan 2, 1050 Brussels

From 2005 until 2009, CROSSTALKS ran a bottom-up and interdisciplinary project “The Future of Medication in a Patient-centered Health Care”, a series of conferences and workshops to develop constructive dialogues between all the partners in the health care sector.

Crucial in this project was the collaborative partnership and sharing of knowledge between academics, industry, physicians, pharmacists, patients, sick funds and insurances, health and social care organizations and policymakers.

Programme: 

Workshop on Access & Transparency (Science and industry lunch 6)

09:00 Registration & Coffee
09:20 Welcome
09:30 Alain Dupont, Vice-dean Research & Head of the Pharmacology Department VUB: “Registration, access and evidence based reimbursement of medicines and orphan drugs.”
10:10 Jacques De Grève, Head of the Medical Oncology Dept UZ Brussel: “The cost and added value of personalized cancer treatment.”
10:50 Coffee Break
11:10 Silvio Garattini, Founder and Director of the Mario Negri Institute for Pharmacological Research, Milano: “Scientific basis for the reimbursement of drugs in the national health service.”
11:50 Julien Brabants, Executive Director Public Affairs GlaxoSmithKline: “Case study - The compensation model.”
12:30 Final discussion
13:00 Apero & Walking lunch

Partners

This project could be realized due to unconditional grants by

Astra Zeneca Foundation
GlaxoSmithKline
Janssen Pharmaceutica
Pfizer
UCB